No Carolina / NY / Florida
Ph: 561.316.3330

Lantheus Holding

aPROMISE Receives CE Mark Reports EXINI Diagnostics AB (Subsidiary of Lantheus Holdings)

aPROMISE includes a solution for automated body segmentation and marking, quantifying and reporting suspicious lesions in their anatomical context. The AI tool provides enhanced consistency in quantitative analysis and is intended to increase efficiency, accuracy and reproducibility of PSMA PET/CT image assessments.
- Advertisement -spot_img

Latest News

Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B

Intuity Medical, Inc., a medical technology company committed to making it easier to live with diabetes, announced today that...
- Advertisement -spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy